Skip to main content

Table 4 The 5-year overall survival Cox proportional multivariate hazards model

From: Does geography influence the treatment and outcomes of colorectal cancer? A population-based analysis

Variable

Event (n (%))

Adjusted HRa

95%CI

P value

Age quartileb

   

<0.0001

  Quartile 1

210 (38.75)

1

  

  Quartile 2

234 (44.83)

1.21

1.00 to 1.46

 

  Quartile 3

266 (50.19)

1.59

1.31 to 1.93

 

  Quartile 4

328 (66.67)

2.07

1.69 to 2.53

 

Gender

   

0.007

  Female

470 (48.81)

1

  

  Male

568 (50.58)

1.19

1.05 to 1.35

 

Site

   

0.755

  Colon

707 (51.38)

1

  

  Rectosigmoid

103 (50.99)

1.06

0.85 to 1.31

 

  Rectum

228 (44.88)

0.96

0.81 to 1.15

 

AJCC stage

   

<0.0001

  I

111 (27.54)

1

  

  II

188 (32.70)

1.44

1.12 to 1.86

 

  III

279 (45.74)

2.22

1.71 to 2.87

 

  IV

412 (93.85)

7.67

5.88 to 10.00

 

  Unknown/NAc

48 (81.36)

3.08

2.14 to 4.45

 

Income quintiled

   

0.004

  Quintile 1

271 (58.66)

1

  

  Quintile 2

240 (52.86)

1.07

0.90 to 1.28

 

  Quintile 3

209 (47.83)

0.95

0.79 to 1.14

 

  Quintile 4

159 (42.51)

0.92

0.75 to 1.13

 

  Quintile 5

137 (40.90)

0.77

0.63 to 0.95

 

  NF

22 (91.67)

1.78

1.14 to 2.78

 

CCI group

   

<0.0001

  CCI count <1

235 (28.08)

1

  

  CCI count = 1

448 (58.56)

2.03

1.70 to 2.42

 

  CCI count >1

355 (73.35)

2.79

2.33 to 3.36

 

RHA group

   

0.314

  Winnipeg

589 (48.84)

1

  

  North Manitoba

36 (55.38)

0.98

0.69 to 1.39

 

  South Manitoba

239 (48.19)

1.16

0.99 to 1.35

 

  Middle Manitoba

174 (54.55)

1.04

0.87 to 1.23

 

Surgery

   

<0.0001

  Major surgery

694 (42.63)

0.54

0.40 to 0.73

 

  Local resection

14 (24.14)

0.33

0.18 to 0.58

 

  Polypectomy

26 (37.14)

0.63

0.40 to 0.97

 

  None

304 (92.12)

1

  

Chemotherapy

   

<0.0001

  No

677 (50.52)

1

  

  Yes

361 (48.39)

0.59

0.50 to 0.69

 

Radiation therapy

   

0.126

  No

916 (51.29)

1

  

  Yes

122 (40.67)

0.84

0.67 to 1.05

 

Lymph nodes removed

   

<0.0001

  0 to 12

249 (47.43)

1

  

  >12

440 (39.43)

0.76

0.65 to 0.89

 

  Unknown/not examinede

349 (78.43)

1.43

1.06 to 1.94

 
  1. All variables listed are included in the full model. aHR >1 relates to higher mortality; bquartile 1: age 20 years to 61 years, quartile 2: age greater than 61 years to 72 years, quartile 3: age greater than 72 years to 80 years, and quartile 4: age greater than 80 years to 103 years; cone or more elements of the AJCC stage is missing or staging scheme is NA; dquintile 1: poorest, quintile 5: richest; eunknown number or no lymph nodes examined. AJCC American Joint Committee on Cancer, CCI Charlson comorbidity index, CI confidence interval, HR hazards ratio, NA not applicable, NF not formatted, RHA regional health authority.